BUSULFEX (Otsuka America Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the BUSULFEX drug offered from Otsuka America Pharmaceutical, Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Otsuka America Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | busulfan |
| SUBSTANCE NAME: | BUSULFAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-02-13 |
| END MARKETING DATE: | 0000-00-00 |
BUSULFEX HUMAN PRESCRIPTION DRUG Details:
| Item Description | BUSULFEX from Otsuka America Pharmaceutical, Inc. |
| LABELER NAME: | Otsuka America Pharmaceutical, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 6(mg/mL) |
| START MARKETING DATE: | 2015-02-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59148-047_950276f8-8e33-4dff-998d-7b66ace11aaf |
| PRODUCT NDC: | 59148-047 |
| APPLICATION NUMBER: | NDA020954 |
Other BUSULFAN Pharmaceutical Manufacturers / Labelers:
